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Quantitative 3D imaging 
parameters improve prediction of 
hip osteoarthritis outcome
T. D. turmezei  1*, G. M. treece  2, A. H. Gee2, S. Sigurdsson3, H. Jonsson4, t. Aspelund  5, 
V. Gudnason5 & K. e. S. Poole6
Osteoarthritis is an increasingly important health problem for which the main treatment remains joint 
replacement. Therapy developments have been hampered by a lack of biomarkers that can reliably 
predict disease, while 2D radiographs interpreted by human observers are still the gold standard for 
clinical trial imaging assessment. We propose a 3D approach using computed tomography—a fast, 
readily available clinical technique—that can be applied in the assessment of osteoarthritis using a new 
quantitative 3D analysis technique called joint space mapping (JSM). We demonstrate the application 
of JSM at the hip in 263 healthy older adults from the AGES-Reykjavík cohort, examining relationships 
between 3D joint space width, 3D joint shape, and future joint replacement. Using JSM, statistical 
shape modelling, and statistical parametric mapping, we show an 18% improvement in prediction 
of joint replacement using 3D metrics combined with radiographic Kellgren & Lawrence grade (AUC 
0.86) over the existing 2D FDA-approved gold standard of minimum 2D joint space width (AUC 
0.73). We also show that assessment of joint asymmetry can reveal significant differences between 
individuals destined for joint replacement versus controls at regions of the joint that are not captured by 
radiographs. This technique is immediately implementable with standard imaging technologies.
Hip osteoarthritis is an enormous health burden estimated to affect one in four individuals in the USA dur-
ing their lifetime1. The American Joint Replacement Registry reported 280,000 primary total hip replacements 
(THRs) performed in 2017 from 854 participating facilities2, with 92,000 THRs registered in the UK for the same 
year3. These are among the most common surgical procedures performed and remain the mainstay of treatment 
for end-stage osteoarthritis.
There are no approved therapies for prevention of osteoarthritis or reversal of progression. A lack of effective 
biomarkers that might facilitate therapeutic clinical trial successes has previously been identified as a serious 
limitation and remains an ongoing challenge4. Until recently, the US Food and Drug Administration (FDA) only 
approved 2D radiographic joint space assessment for clinical trial imaging endpoints5, although it appears that 
these guidelines will be relaxed to include cross-sectional imaging with the aim of facilitating therapy develop-
ment6. This is an opportunity for a change in approach to imaging assessment of joints, particularly in how to 
identify relevant structural changes as they fail.
Historically the OARSI-OMERACT (Osteoarthritis Research Society International–Outcome Measures in 
Rheumatology) defined relevant radiological progression at both the hip and knee as progressive loss of joint 
space width (JSW)7. Clinical and epidemiological studies define disease with radiographic Kellgren and Lawrence 
(KL) grading8, but the KL system has been shown to suffer from variable interpretation9. However questions have 
been raised over the link between symptomatic hip osteoarthritis and radiographic findings, with concerns that 
clinical cases of hip osteoarthritis might be missed if radiographs alone were relied on for diagnosis10.
In the clinical environment, the traditional American College of Rheumatology (ACR) classification crite-
ria for hip osteoarthritis allow for the inclusion of radiographic joint space narrowing. These were under peer 
review at the time of publication11,12. In the UK, the National Institute for Health and Care Excellence (NICE) 
guidelines from 2014 do not recommended the use of imaging in the diagnosis of osteoarthritis13. Yet the role of 
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radiographic imaging in stratification and assessment of disease progression for research studies and clinical trials 
has remained unchallenged.
Assessment of radiographs and, in most circumstances, MRI relies on 2D images being interpreted by human 
observers to give a semiquantitative score or grade of disease: for example the KL system grades from 0 to 4 
(equating to none-possible-mild-moderate-severe)8. Beyond morphological cartilage thickness measurement14, 
other quantitative MRI techniques such as compositional T2, T1rho, ultrashort echo and dGEMRIC (delayed 
gadolinium enhanced MRI of cartilage) time measurements have been developed, but their role in prognosti-
cation is yet to be clearly defined15,16. Semiquantitative MRI scoring systems have also been developed for the 
assessment of disease at the hip (HOAMS) and knee (MOAKS)17,18. No single MRI technique has come to the fore 
as an effective predictor of clinically relevant disease states or outcomes.
Given the lack of success so far in finding a solution, our idea was to take a step back from MRI towards the 
current standard of 2D radiographic JSW measurement, then look for a direct improvement on this.
CT, like radiography, is an x-ray based clinical imaging technique, but unlike radiography it has the ability 
to create large and accurate 3D imaging data volumes. Already an essential clinical technique, CT also plays 
an important role in osteoarthritis research and has been implemented in epidemiological cohort studies (the 
Multicenter Osteoarthritis Study) using dual energy and standing knee CT, and with low dose whole body CT 
(the APPROACH study). CT has been mainly used for investigating diagnostic potential, but not yet disease 
monitoring or prognostication19. Our aim has been to develop an image analysis technique that uses clinical CT 
imaging to reveal the distribution of JSW in 3D, believing that it could outperform current gold standard 2D 
imaging approaches, while accepting this is likely to come at the cost of increased radiation dose.
The joint space is essentially laminar and, in some situations, thinner than the resolution of the CT data we 
would like to use to measure it. Imaging system blur, also known as point spread function (PSF), sets the limit 
below which features cannot be measured accurately. In CT this is often approximated as a simple function with 
a Gaussian profile. Modern CT systems can be optimised to improve image resolution, but substantial gains can 
only be achieved at the cost of increased noise unless radiation dose is also increased, which is undesirable. JSW 
distances at relatively narrower joints such as the hip or ankle (compared to the knee), or with more advanced 
degenerative joint disease at any joint, can be below this threshold.
In order to achieve accurate measurements of JSW from CT imaging, we remove this blur using a constrained 
deconvolution approach, where the constraint—here prior knowledge of bone density around the joint space—
acts to limit noise in measurement while still improving accuracy. We call this approach joint space mapping 
(JSM). This process is repeated at multiple locations each in a different direction, to yield quantitative JSW meas-
urements in 3D. It has been recently validated as accurate and reliable, with twice the reported reliability of radi-
ographic 2D minimum JSW measurement20.
The ability to map JSW in 3D also delivers an opportunity to revisit a rarely considered phenomenon. 
Experience from our clinical practice has shown that one hip tends to degenerate prior to the opposite, as demon-
strated in Fig. 1. To the best of our knowledge, only two previous studies have specifically commented on radi-
ographic JSW asymmetry21,22. The first, by Reis et al. in 1999, looked at the difference in superior JSW in 171 
individuals without hip pain or radiographic evidence of disease, concluding that side differences in JSW greater 
than 0.7 mm at the superior joint space strongly suggested pathological joint narrowing. In 2004, Lequesne et al. 
then examined the same superior locations for radiographic minimum JSW and concluded that asymmetry was 
rare, seeing a difference greater than their limits of agreement (1.45 mm) in only 13 out of 221 subjects (5.9%)22. 
Using the opposite hip could provide an approach for a single time-point assessment of osteoarthritis risk from 
this internal comparison.
In this paper we describe the JSM process and its first application in a clinical cohort of healthy older adults 
using 3D statistical analysis. Section 2 describes the technical details of JSM, previously introduced in the valida-
tion study published in 2018, but because they are fundamental to the technique warrant revisiting here20. Section 
3 describes the clinical cohort and CT imaging on which JSM and subsequent 3D statistical analyses were per-
formed. Section 4 then uses a statistical shape model (SSM—a by-product of the JSM process) to look at 3D shape 
Figure 1. Anteroposterior radiographs of the pelvis in two adult females. The individual in (a) has no evidence 
of radiological osteoarthritis on either side (KL grade 0); however, the individual in (b) has marked disease 
asymmetry, with no radiological disease in the right hip (KL grade 0), but moderate disease in the left (KL grade 3).
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variation across the study cohort, and the relationships of 3D shape modes with clinical outcome of future THR. 
Section 5 examines the dependence of 3D JSW on these same factors using statistical parametric mapping (SPM). 
In this section we explore two specific hypotheses: (1) 3D JSW measurement would be significantly different in 
cases with future THR compared to controls; and (2) the same would be the case for the side-side difference in 3D 
JSW as a measure of joint asymmetry. In section 6 we apply a predictive model for future THR using parameters 
derived from these analyses, with the hypothesis that quantitative 3D image analysis would perform better than 
current standard 2D measures. Finally, in section 7, we discuss these results and their implications for imaging 
approaches to structural joint disease.
Joint Space Mapping (JSM)
Joint space mapping analysis uses standard clinical CT imaging data to create maps of joint space width distri-
bution in 3D. The first step is to segment the proximal femur from cross-sectional (axial) CT data, from which a 
triangulated mesh is constructed using regularised marching tetrahedra23. We employ a semi-automatic manual 
segmentation approach, which can be guided by a shape model, however segmentations can also be performed 
with any appropriate manual, semi-automatic, or automatic technique. 3D joint space patch segmentation is then 
performed for each hip joint: the perimeter of the joint space is set by the shadow of the acetabulum projected 
back onto the 3D proximal femoral surface (Fig. 2).
Each vertex in the joint space patch (yellow in Fig. 3, steps 1 to 4), is a measurement point at which a 1D sam-
ple line is passed through the 3D imaging data volume at a normal to the object surface (Fig. 3, step 3). The aver-
age number of vertices in a joint space patch in the clinical study we describe in this paper is ~2,000, ranging from 
1,250 to 3,500 depending on the size and extent of the acetabulum. A Gaussian function is fitted to the interpo-
lated imaging data along this sample line (solid red curve fitted to the cyan curve in step 3, Fig. 3), using an opti-
miser. This optimiser presumes a fixed cortical density for each joint space patch (the horizontal tops of the solid 
red step functions in the same graph). Other parameters of the Gaussian function, including the location of the 
subchondral bone edges at the joint space (the vertical lines of the solid red line step functions) are determined 
by the optimiser. This deconvolution approach to the 3D measurement of a laminar structure in CT imaging data 
has been described by Treece et al.24. The distances between outer subchondral bone layers at the joint is taken 
as JSW (Fig. 3, steps 3 & 4). Independent JSW measurements for each vertex in the original joint space patch are 
smoothed to reduce noise and cover any missing measurements due to occasional failure of the optimiser to con-
verge on a solution. The subsequent measurements at every vertex can be used to generate new 3D joint surfaces 
which precisely locate the subchondral bone edges. All these steps are performed using Stradwin, software freely 
available to download at http://mi.eng.cam.ac.uk/~rwp/stradwin/.
Technical validation for the accuracy, precision, and reproducibility of this technique has been previously 
reported20. In contrast to the originally published technique, density estimation in this paper is performed on the 
joint space patch rather than the whole proximal femur. This preserves the concept of estimating density from the 
object on which measurements are performed, giving an estimate of peak cortical density from subchondral bone 
local to the joint rather than from femoral cortex at more distant trochanteric and subtrochanteric regions24. A 
comparison of JSW values from both techniques showed that across the total of ~1.1 million measurement points, 
there was a systematic overall underestimation of only 0.2 mm compared to the high resolution CT gold standard 
from Turmezei et al. in 2018 (compared to an overestimation of 0.1 mm in that study)20.
As shown in Fig. 3 (steps 5 to 7), data output from JSM is fundamentally surface-based. SPM is an appropriate 
analysis tool for such data, but each individual joint space first needs to be mapped to the same canonical 3D 
acetabular joint surface, shown in relation to a canonical proximal femur in Fig. S1. This surface contains approx-
imately 2,300 vertices and was created from the 20 test subjects in the JSM validation study20. It is registered to 
all individual acetabular surfaces in turn using a similarity transformation with an iterative closest point (ICP) 
Figure 2. Segmenting and extracting the 3D joint space patch (yellow) around the perimeter of the shadow of 
the acetabulum projected back onto the 3D proximal femoral object surface (from Turmezei et al.)20. Images are 
from the Stradwin software (http://mi.eng.cam.ac.uk/~rwp/stradwin/).
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registration algorithm. This is followed by a thin plate spline transformation that includes matching the rims of 
the two objects (Fig. 3, steps 5 & 6)25. JSW measurements are transferred from each individual acetabular surface 
to the canonical surface at closest neighbouring vertices, then smoothed further as required for SPM analysis. 
These steps are performed in wxRegSurf, software freely available at http://mi.eng.cam.ac.uk/~ahg/wxRegSurf/.
For side difference 3D JSW maps, data mapped onto the canonical surface from left and right hips in the same 
individual are subtracted from each other: the replaced hip minus the opposite side; random side selection if both 
replaced; and according to case side-matching by random selection in controls.
Clinical Cohort Study
Study groups. We undertook a nested case-control study within the prospective AGES-Reykjavik cohort of 
3,133 healthy older adults, the design and recruitment of which have been described in detail26. After initial 2:1 
matching of all THR cases for age and gender, exclusion criteria were: THR for fracture rather than osteoarthritis 
(16 hips); movement artefact (6 hips); incomplete joint coverage (2 hips); and joint ankylosis (1 hip). This gave 80 
case individuals with a THR performed on at least one side in the subsequent 5 years and 187 controls who had 
neither hip replaced in the same period. 2 hips in each group were unpaired, leaving 78 case individuals and 185 
control individuals with both hips for subsequent SPM analysis of both standard 3D JSW and side difference in 
3D JSW—see Table 1. 17 individuals in the THR case group had both hips replaced within the 5-year follow-up 
period. Hip pain (HP) at study baseline was recorded if there was any pain in either hip for more than one con-
tinuous month in the last year. From all 263 individuals with imaging of both hips, 53 had hip pain at baseline (14 
on both sides), while 210 individuals had no pain.
There were no significant differences between THR cases and non-THR controls according to age at the time 
of imaging and study baseline BMI according to a 2-tailed t-test, or sex according to the chi-squared test (p > 0.05 
in all cases). All 530 available hips were used in 3D SSM analysis (see Table 1).
CT imaging acquisition. All CT imaging was acquired helically in the supine position at study base-
line using a 4-detector clinical CT system (Sensation 4, Siemens Medical Systems, Erlangen, Germany) with 
Figure 3. The joint space mapping pathway (1–4), which requires registration and data transfer to a canonical 
acetabular surface (steps 5 to 7) for analysis with statistical parametric mapping and statistical shape modelling. 
3D vectors at each vertex from the registration of the canonical surface to the subject surface (Step 6) are used as 
the input for principal component analysis.
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the following parameters: 120 kVp, 140 mAs, 1 mm slice thickness, pitch of 1, pixel size 0.977 mm, matrix size 
512 × 512. Hip positioning was not controlled at the time of acquisition. The study imaging protocol was to scan 
a range from 10 mm superior to the acetabulum to at least 3 mm inferior to the lesser trochanter (2 individuals 
were excluded from failure of adherence to this imaging protocol, as above). The same proprietary smooth image 
reconstruction kernel was automatically applied to all acquisitions.
The approximate dose for an examination was ~2.5 mSv, with a mean ± SD dose length product (DLP) across 
the cohort of 280.15 ± 27 mGy.cm and weighted CT dose index (CTDIw) of 21.6 ± 0 mGy. According to the guide-
lines for radiation protection from the International Commission on Radiological Protection (ICRP Publication 
62, Radiological Protection in Biomedical Research, Annals of the ICRP 22 (3) 1991), the risk of biological dam-
age due to ionizing radiation is considered to decrease with age, such that for participants age 70–80 years is 1/5th 
to 1/10th lower than it would be for participants aged 50 years, noting that the mean age of the participants in this 
study was 74.3 ± 4.9 yrs.
Radiographic disease scoring. KL grade and then minimum 2D joint space width (JSW) had been previ-
ously recorded for each hip by a single blinded observer as part of a separate study in 2014 with a method digitally 
reconstructing radiographs from the CT data27. The distributions for these scores across all hips from the study 
are shown in Fig. S2 and Table S1.
Ethical approval and informed consent. The AGES-Reykjavik study was approved by the Icelandic 
National Bioethics Committee, (VSN: 00–063), which acts as the Institutional Review Board for the Icelandic 
Heart Association, and from the Data Protection Authority. Approval for the current study was received from 
the AGES-Reykjavik executive committee on 28th August 2015. Written informed consent for use of data had 
previously been obtained from all participants. All methods were performed in accordance with the relevant 
guidelines and regulations.
Statistical Shape Modelling
Joint space mapping creates sets of vertices for corresponding 3D femoral and acetabular surfaces at each hip 
(orange and blue surfaces respectively in Fig. 3), each vertex pair separated by a vector with the magnitude of 
JSW and a direction perpendicular to the original joint space patch surface cut from the proximal femur. As 
each surface is a triangulated mesh, the registration of the canonical surface to each individual acetabular surface 
(Fig. 3, steps 5 & 6) generates a 3D vector for each vertex as it is displaced towards the other surface. We then use 
principal component analysis (PCA) to determine orthogonal modes of shape variation from the average acetab-
ular surfaces in the cohort28.
Horn’s parallel analysis showed that the first 16 shape modes were greater than noise in the PCA coefficient 
matrix (Fig. S3)29, while the first 7 shape modes accounted for up to 90% of overall shape variation.
In order to control for the clustering effect of two hips coming from one individual, generalised estimating 
equations (GEEs)30 were used to calculate odds ratios (ORs) for association of shape modes with future THR, 
including age and BMI in the model; sex was not included because of its strong association with shape mode 1 
(r2 = 0.70) and the risk of multicollinearity, but its effect is therefore represented by this mode. OR values were 
calculated for each SD increment in shape mode coefficient, with the SD value adjusted according to the equiv-
alent number of paired hips in the analysis as weighted by 1/(1 + R), where R is the correlation between shape 
mode coefficients from the two sides in the same individual (Table 2)31. The threshold for significance values was 
reduced from p < 0.05 using a Bonferroni correction factor of 18 (16 shape modes, plus age and BMI), making 
p < 0.003 the conservative significance threshold.
We present the first 7 shape mode as 3D point clouds ±3 SD from the mean cohort shape (Fig. S4), as well as 
showing the mean shapes for future THR cases compared to controls (Fig. 4).
These 3D SSM results suggest that a smaller joint space (shape mode 1 and, by correlation, also being female), 
increased acetabular coverage medially and laterally (shape mode 2), and a skew in the anterior and posterior 
joint space limbs (shape mode 6) pose an increased risk for future THR. However, caution is required in the inter-
pretation of these results, since registration of these objects are somewhat arbitrary due to the ill-posed object 
matching problem, with different registrations potentially capable of delivering different results. We chose what 
we believe is the current best approach.
n hips n ind. Age (yrs) Sex Ht (cm) Wt (kg) BMI (kg/m2)
ALL HIPS
Controls 433* 187 74.3 ± 4.9 164 M 282 F 167.6 ± 9.2 77.5 ± 13.5 27.6 ± 4.2
THR cases 97 80 74.4 ± 4.9 35 M 62 F 167.0 ± 8.5 77.5 ± 12.6 27.8 ± 4.2
p value — — 0.88 0.90 0.58 0.98 0.62
PAIRED HIPS
Controls — 185 74.3 ± 4.9 68 M 117 F 167.6 ± 9.3 77.5 ± 13.7 27.5 ± 4.2
THR cases — 78 74.3 ± 4.7 28 M 50 F 167.9 ± 8.8 77.7 ± 12.9 27.9 ± 4.4
p value — — 0.92 0.89 0.58 0.91 0.52
Table 1. Demographics of the analysis groups. There were no significant group-wise relationships (p < 0.05). 
*This number includes the non-THR hips from the THR case individuals.
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Statistical Parametric Mapping
Statistical parametric mapping (SPM) was performed on all 263 individuals with imaging of both hips to look for 
regions of 3D JSW and its side difference that might be significantly different between THR cases and the control 
group. SPM is a 3D statistical analysis technique initially developed for application in neuroimaging to allow 
regionally located statistical inferences to be made from the comparison of data at multiple points. SPM uses a 
general linear model (GLM) at every point on the surface to account for variability in measurement data in terms 
of experimental and confounding factors32. Here we apply it to surface distributed JSW data in a similar fashion 
to previous studies that have looked at the relationship between cortical bone parameters and hip fracture type33. 
3D JSW maps and shape mode coefficients, for both hips from the same subject, whether in bilateral THR cases 
or the control group, were averaged to account for cluster bias from within-subject correlation.
The SPM general linear model included THR outcome as the experimental effect and shape modes (SMs) 1 
to 7 as confounding effects, given that they make up to 90% of overall shape variation (Eq. 1). This approach is 
applied to account for systematic registration bias that might alter significance of results34.
= + + + + + + + +JSW 1 THR SM1 SM2 SM3 SM4 SM5 SM6 SM7 (1)
Age and BMI did not have any effect on results and were therefore not included in this model. Sex was 
removed to avoid multicollinearity because of its correlation with shape mode 1 (r2 = 0.7), but in any case did not 
have an effect on results when tested. No other covariate correlation was above 0.4. Standard two-tail F testing 
across the cohort gave p-values at each measurement location that were uncorrected for multiple comparisons. As 
required for SPM, random field theory furnished p-values corrected for multiple comparisons to control for false 
positive results (type I errors)32. Significant result clusters are shown as unmasked region of interests (ROIs) over 
the mean difference between THR cases and controls, each of which are mapped onto the canonical acetabular 
surface in 3D. This SPM analysis was performed in MATLAB 2018a (© 1984–2018, The MathsWork, Inc.) using 
the Surfstat package35.
SPM revealed a large ROI across the superior joint space in which 3D JSW was significantly dependent on 
future THR (p < 0.05), narrower in THR cases compared to controls by up to 1 mm (Fig. 5, left, bottom row). 
Although non-significant, there was a trend for the joint space to be wider by up to ~0.5 mm posteriorly, 
OR (±1.96 × SE limits) p value Description
Age 0.99 (0.93–1.05) 0.81 —
BMI 0.98 (0.91–1.04) 0.44 —
Shape mode 1 1.43 (1.16–1.77) 0.0001* Scale
Shape mode 2 1.75 (1.40–2.20) 0.00001* Acetabular expanse from central to outer joint
Shape mode 3 1.37 (1.15–1.63) 0.0098 Squatness to the anterior aspect of the joint
Shape mode 4 1.02 (0.86–1.20) 0.88 Anterior and posterior joint limb convergence
Shape mode 5 0.88 (0.71–1.09) 0.28 Acetabular depth/shallowness
Shape mode 6 1.39 (1.15–1.68) 0.001* Anterior-posterior skew
Shape mode 7 1.18 (0.98–1.40) 0.13 Width across the anterosuperior joint space
Table 2. Odds ratios (ORs) with ±1.96 × SE (standard error) limits for future THR. ORs for shape mode are 
for one standard deviation increment in mode coefficients. Significant results below the conservative Bonferroni 
corrected threshold of p < 0.003 are emboldened and marked with*. No shape mode beyond 7 met significance, 
with these results presented in Table S2.
Figure 4. The average shape of future THR hips compared to non-THR cases using all shape modes. Each point 
in the plots is a vertex displaced from the canonical model by a vector representing the mean displacement for 
the given study group (THR cases in red, controls in blue). The vector magnitudes have been increased by a 
factor of 3 to emphasise differences. See supplementary material for a dynamic 3D visualisation.
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suggesting that the femoral head migrates anterosuperiorly in the acetabulum as the joint fails. This zone of 
SPM significance was used as the ROI from across which a minimum 3D JSW value was taken forward to the 
prediction model, divided by the global mean 3D JSW to deliver a single parameter (min3D, Section 6). A smaller 
significant region was identified for side difference in 3D JSW across the superior joint space of up to 1 mm asym-
metry (Fig. 5, right, bottom row), but also with a region significantly wider by up to ~0.75 mm in the posterior 
joint space, again suggesting that there is a tendency for failing hips to migrate anterosuperiorly.
ROC Analysis for Future THR Prediction
Receiver operating characteristic (ROC) curves with area under the curve (AUC) values were calculated using 
a leave-one-out cross-validation of a predictive model for future THR. This model used baseline hip pain (HP), 
KL grade, minimum 2D JSW (min2D), minimum 3D JSW within the SPM significance region of interest (ROI) 
divided by mean global 3D JSW (min3D), and the first 7 shape mode coefficients (SM) accounting for 90% of 
overall shape variation. This analysis was also performed in MATLAB 2018a (© 1984–2018, The MathsWork, 
Inc.)
This predictive model for future THR showed that hip pain was the poorest predictor (AUC = 0.69). KL grade 
(0.72), minimum 2D JSW (0.73) and the first 7 shape mode coefficients (0.74) were all similar, while there was a 
slight improvement for minimum ROI 3D JSW relative to the global mean (0.79). AUC increased for combined 
3D JSW and shape mode data (0.81) and was further improved when KL grade was also included (0.86), an 18% 
improvement on the FDA approved standard of minimum 2D joint space width measurement (Fig. 6).
Discussion
Previous studies looking at the prediction of total hip replacement (THR) in older adults have identified KL 
grade, mean patient global assessment, NSAID use, and 2D hip shape as important factors36–38. We show here 
that 3D joint space width (JSW) is significantly dependent on future THR status across the superior joint space, 
narrower here by up to 1 mm in individuals having a THR within the next 5 years. This result is in keeping with 
the known distribution of joint space narrowing from radiographic studies, but it is the first time that this has 
been established in 3D. These 3D measures also show greater predictive ability than traditional 2D radiographic 
metrics alone. Testing the dependence of future THR against the side difference revealed a similar difference in 
joint space distributions, but also showed that the joint space was significantly wider posteriorly, a region that is 
not assessable with current radiographic standards. These results demonstrates how a 3D approach can reveal 
hitherto unappreciated relationships between structural disease and clinical status, a link that has been strongly 
questioned in 2D radiographic imaging10.
Indeed, radiographic measures of JSW loss can only distinguish between superomedial, superolateral, and 
more complete superior joint space loss21,22. The two relevant studies we described in Section 1 performed man-
ual measurement of radiographic film with a magnifying glass, showing that asymmetry was most common at 
the superolateral site21,22, which we can corroborate with our 3D JSW analysis results. However, our results also 
show that JSW change can occur in multiple directions, which JSM can demonstrate on a case-by-case basis as in 
Fig. S5, or across a study cohort as we have done here with SPM.
3D statistical shape modelling showed that three of the first seven acetabular surface shape modes had sig-
nificant ORs for future THR (modes 1, 2, and 6). Verbal description of these shape modes is a difficult process 
Figure 5. SPM results from the THR experiments. The left side of the plot shows (1) standard 3D JSW 
measurement; the right side of the plot shows (2) side difference in 3D JSW.
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since they can be abstract, but one overwhelming feature that JSM has revealed is the tendency for hips that have 
disease to have increased medial coverage, a phenomenon that can be explained by the presence of encroaching 
osteophytes (shape modes 2 and Fig. S5(d)), but one that has never been shown before to be of predictive value. 
To the best of our knowledge, only one previous study has analysed 3D hip shape using the proximal femur from 
MRI imaging data with an SSM to show association with other imaging features of osteoarthritis, but none have 
ever examined the acetabular shape in 3D, or the joint its entirety whether in 2D or 3D39. These shape modes 
may also have implications in the form of altered 3D biomechanics as a joint fails, which would be of interest to 
address in future studies.
Averaging all the THR acetabular surfaces compared to respective controls separately revealed differences in 
their shape, with future THR hips tending to be smaller, broader across the anterior and posterior regions of the 
joint space, and with increased coverage of the acetabular fossa (Fig. 4). It should also be considered that any rela-
tionship of scale with disease risk could arise from the strong association of shape mode 1 with sex, with females 
having smaller hips. These shape results are similar to those published by Agricola et al.40, who showed that sig-
nificant 2D shape modes from radiographs associated with an increased risk of future THR within 5 years had an 
AUC of 0.81 in a predictive model. In our model, combining 3D parameters of relative minimum 3D JSW and 3D 
shape mode data outperformed the current 2D radiographic gold standards of KL grade and minimum 2D JSW 
with an AUC of 0.81 compared to 0.72 and 0.73 respectively, an improvement of 10–12%. All imaging parameters 
outperformed baseline hip pain (AUC 0.69), while a combination of KL grade and 3D JSM parameters achieved 
very good prediction of future THR within 5 years with an AUC of 0.86, 0.14 better than KL grade alone and 0.13 
than minimum 2D joint space width, an improvement of 18–19%. One recent study showed that imaging factors 
enhanced a basic model for prediction of incident hip radiographic osteoarthritis that encompassed demographic 
and questionnaire data41, but the best AUC achieved was 0.74 for this combined model, whereas we have shown 
an ability to predict future THR with imaging features alone when including 3D data.
Limitations
By using THR as an outcome in this study, we recognise that we are predicting end-stage disease in an older 
population that are more likely to have a joint replacement for more advanced disease than a relatively younger 
population. Although CT imaging was acquired in the supine position, one previous study has shown that there 
is unlikely to be any difference in JSW values between standing and supine acquisitions42. This issue is currently 
void for CT acquisition because current technologies do not yet acquire standing CT at the hip joint. We also 
recognise that standardised positioning of the hip joints was not set during image acquisition, but significant 
results were achieved in the retrospective analysis of prospectively collected data despite noise that uncontrolled 
positioning might introduce. Future studies could control for this by wrapping the knees and ankles together at 
the time of acquisition, with knees flat on the CT gantry. Cone beam CT (CBCT) is a well-established technique 
that holds promise not only for dose reduction, but also opening up further opportunity for JSM to be used in 3D 
biomechanical assessment of the hip joints in a standing position. We also recognise that our radiographic meas-
ures of disease were performed using digitally reconstructed radiographs of CT imaging data and were therefore 
not true radiographs, but these were not available from the study cohort and so we created the best available alter-
native, which has been used to generate radiographic scores in previously published studies27,43. This may lead to 
a slightly different interpretation of KL grade, but assessment has been shown to be reliable, and the effect would 
Figure 6. ROC curves with AUC values for each of the predictive models for future THR.
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be systematic. Importantly, the registration of our joint surfaces is also an ill-posed problem, and although we 
know that our technique allows representation of results on a canonical surface in 3D for SPM analysis (in which 
we account for shape), there is no guarantee that other registration techniques might not deliver slightly different 
results that could affect significance in repeat regression or predictive analyses; this problem needs further atten-
tion from a morphometric perspective to seek a suitable solution, as would all shape mode analysis studies that 
are not underpinned by well-defined homologous landmarks.
Conclusion
3D joint space mapping of standard clinical CT imaging results in substantially better prediction of future THR 
than current 2D radiographic gold standards in healthy older individuals. At best, we have been able to show an 
18% improvement using 3D measures with KL grade over the FDA-approved measure of minimum 2D radi-
ographic joint space width. This method also shows significant differences in JSW between cases and controls 
across regions that are undetectable using radiographic techniques by looking at JSW asymmetry, namely the 
posterior joint space. We have also demonstrated for the first time that 3D shape of the acetabulum has significant 
associations with future THR. Contrary to the message from a recent large-scale study from the Framingham and 
OAI cohorts10, this work suggests that imaging should remain relevant for hip osteoarthritis assessment when 
enhanced with 3D information, while also raising the important question of whether similar improvements can 
be achieved from the application of JSM at other joints such as the knee and ankle. This is not a claim that the 
technique should be expedited into clinical practice, but our opinion is that it should be further explored in many 
of the roles that radiographs undertake in exploratory research and clinical trials to see what further improve-
ments can be gained. Given that JSM has already been shown to have reliability at best twice that of radiographs20, 
we have presented evidence here suggesting a need to rethink the approach to x-ray based imaging assessment of 
osteoarthritis to encompass 3D information. An important question is whether this can be achieved with mini-
mal increased risk from radiation exposure that comes with CT, particularly at the hip, noting that reduced dose 
protocols that would be suitable for these purposes are already available44. CBCT holds promise for JSM, both 
through its reduced dose and the opportunity to investigate weightbearing lower limb joints in 3D, which could 
also lead to further important biomechanical insights into osteoarthritis. We believe these results advocate the 
use of JSM in research and epidemiological studies as an adjunct to other non-ionising radiation techniques such 
as MRI and ultrasound, with further exploration warranted into its utility in roles such as disease stratification, 
monitoring, and outcome prediction.
Data availability
• Stradwin is freely available to download from http://mi.eng.cam.ac.uk/~rwp/stradwin/.
• wxRegsurf is freely available to download from http://mi.eng.cam.ac.uk/~ahg/wxRegSurf/.
• The Surfstat package is freely available to download from http://www.math.mcgill.ca/keith/surfstat/surfstat.zip.
• All CT imaging data are anonymised but are not publicly available due to protection of patient identity and 
confidentiality in accordance with the AGES-Reykjavik cohort study ethics. Reasonable requests for sharing of 
this data can be made to the study committee through Sigurdur Sigurdsson.
• All JSM output data (acetabular object surfaces, 3D joint space width thickness and error maps, and 
object-to-canonical registration files) have been uploaded to the PURE University of East Anglia data repository 
and can be made available on request through Tom Turmezei.
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